# | Title | Journal | Year | Citations |
---|
1 | Withdrawal of cerivastatin from the world market | Current Controlled Trials in Cardiovascular Medicine | 2001 | 329 |
2 | Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors | Current Controlled Trials in Cardiovascular Medicine | 2005 | 198 |
3 | Problems in dealing with missing data and informative censoring in clinical trials | Current Controlled Trials in Cardiovascular Medicine | 2002 | 134 |
4 | Are statins anti-inflammatory? | Current Controlled Trials in Cardiovascular Medicine | 2000 | 84 |
5 | Effect of increased convective clearance by on-line hemodiafiltration on all cause and cardiovascular mortality in chronic hemodialysis patients – the Dutch CONvective TRAnsport STudy (CONTRAST): rationale and design of a randomised controlled trial [ISRCTN38365125] | Current Controlled Trials in Cardiovascular Medicine | 2005 | 82 |
6 | Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study | Current Controlled Trials in Cardiovascular Medicine | 2001 | 78 |
7 | The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial | Current Controlled Trials in Cardiovascular Medicine | 2001 | 73 |
8 | Effect of rosuvastatin on outcomes in chronic haemodialysis patients – design and rationale of the AURORA study | Current Controlled Trials in Cardiovascular Medicine | 2005 | 71 |
9 | Systematic adjudication of myocardial infarction end-points in an international clinical trial | Current Controlled Trials in Cardiovascular Medicine | 2001 | 66 |
10 | Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone | Current Controlled Trials in Cardiovascular Medicine | 2002 | 66 |
11 | Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction | Current Controlled Trials in Cardiovascular Medicine | 2005 | 51 |
12 | Methodological considerations in the design of trials for safety assessment of new drugs and chemical entities | Current Controlled Trials in Cardiovascular Medicine | 2005 | 40 |
13 | Cytokines as new treatment targets in chronic heart failure | Current Controlled Trials in Cardiovascular Medicine | 2001 | 39 |
14 | Pooling, meta-analysis, and the evaluation of drug safety | Current Controlled Trials in Cardiovascular Medicine | 2002 | 39 |
15 | Therapeutic angiogenesis for cardiovascular disease | Current Controlled Trials in Cardiovascular Medicine | 2001 | 38 |
16 | A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics | Current Controlled Trials in Cardiovascular Medicine | 2002 | 38 |
17 | Why do antioxidants fail to provide clinical benefit? | Current Controlled Trials in Cardiovascular Medicine | 2000 | 36 |
18 | The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423] | Current Controlled Trials in Cardiovascular Medicine | 2005 | 34 |
19 | Long-term outcome after coronary stenting | Current Controlled Trials in Cardiovascular Medicine | 2000 | 33 |
20 | Effects of a comprehensive cardiac rehabilitation program on quality of life and exercise tolerance in women: A retrospective analysis | Current Controlled Trials in Cardiovascular Medicine | 2003 | 32 |
21 | Implications of troponin testing in clinical medicine | Current Controlled Trials in Cardiovascular Medicine | 2001 | 31 |
22 | Genetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factors for venous thromboembolism in women | Current Controlled Trials in Cardiovascular Medicine | 2001 | 31 |
23 | The role of dyslipidemia and statins in venous thromboembolism | Current Controlled Trials in Cardiovascular Medicine | 2001 | 31 |
24 | Cardiac rehabilitation: a comprehensive review | Current Controlled Trials in Cardiovascular Medicine | 2001 | 29 |
25 | Beyond the Evidence of the New Hypertension Guidelines. Blood pressure measurement – is it good enough for accurate diagnosis of hypertension? Time might be in, for a paradigm shift (I) | Current Controlled Trials in Cardiovascular Medicine | 2005 | 29 |
26 | Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy? – A systematic review | Current Controlled Trials in Cardiovascular Medicine | 2005 | 28 |
27 | Symptomatic relief precedes improvement of myocardial blood flow in patients under spinal cord stimulation | Current Controlled Trials in Cardiovascular Medicine | 2005 | 27 |
28 | Design of the Intravenous Magnesium Efficacy in Acute Stroke (IMAGES) trial | Current Controlled Trials in Cardiovascular Medicine | 2000 | 26 |
29 | Elevated levels of matrix metalloprotein-3 in patients with coronary aneurysm: A case control study | Current Controlled Trials in Cardiovascular Medicine | 2004 | 26 |
30 | Importance of the TIMI frame count: implications for future trials | Current Controlled Trials in Cardiovascular Medicine | 2000 | 24 |
31 | New insights into the effects on blood pressure of diets low in salt and high in fruits and vegetables and low-fat dairy products | Current Controlled Trials in Cardiovascular Medicine | 2001 | 24 |
32 | Distal protection devices during percutaneous coronary and carotid interventions | Current Controlled Trials in Cardiovascular Medicine | 2001 | 23 |
33 | The SPHERE Study. Secondary prevention of heart disease in general practice: protocol of a randomised controlled trial of tailored practice and patient care plans with parallel qualitative, economic and policy analyses. [ISRCTN24081411] | Current Controlled Trials in Cardiovascular Medicine | 2005 | 23 |
34 | The Myocardial Ischemia Reduction with Acute Cholesterol Lowering (MIRACL) trial: a new frontier for statins? | Current Controlled Trials in Cardiovascular Medicine | 2001 | 22 |
35 | Equivalence and noninferiority trials – are they viable alternatives for registration of new drugs? (III) | Current Controlled Trials in Cardiovascular Medicine | 2004 | 22 |
36 | A randomized controlled trial of an extensive lifestyle management intervention (ELMI) following cardiac rehabilitation: study design and baseline data | Current Controlled Trials in Cardiovascular Medicine | 2002 | 21 |
37 | Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention | Current Controlled Trials in Cardiovascular Medicine | 2001 | 20 |
38 | Weight-modification trials in older adults: what should the outcome measure be? | Current Controlled Trials in Cardiovascular Medicine | 2002 | 20 |
39 | Informative noncompliance in endpoint trials | Current Controlled Trials in Cardiovascular Medicine | 2004 | 19 |
40 | The Blood Pressure "Uncertainty Range" – a pragmatic approach to overcome current diagnostic uncertainties (II) | Current Controlled Trials in Cardiovascular Medicine | 2005 | 19 |
41 | Design of a trial evaluating myocardial cell protection with cariporide, an inhibitor of the transmembrane sodium-hydrogen exchanger: the Guard During Ischemia Against Necrosis (GUARDIAN) trial | Current Controlled Trials in Cardiovascular Medicine | 2000 | 17 |
42 | A Review of the Adverse Effects of Peripheral Alpha-1 Antagonists in Hypertension Therapy | Current Controlled Trials in Cardiovascular Medicine | 2002 | 17 |
43 | Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696] | Current Controlled Trials in Cardiovascular Medicine | 2005 | 17 |
44 | Compliance of a cobalt chromium coronary stent alloy – the COVIS trial | Current Controlled Trials in Cardiovascular Medicine | 2005 | 16 |
45 | How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2) | Current Controlled Trials in Cardiovascular Medicine | 2001 | 12 |
46 | Long-term vitamin E supplementation fails to reduce lipid peroxidation in people at cardiovascular risk: analysis of underlying factors | Current Controlled Trials in Cardiovascular Medicine | 2002 | 12 |
47 | Design of a randomized controlled trial of comprehensive rehabilitation in patients with myocardial infarction, stabilized acute coronary syndrome, percutaneous transluminal coronary angioplasty or coronary artery bypass grafting: Akershus Comprehensive Cardiac Rehabilitation Trial (the CORE Study) | Current Controlled Trials in Cardiovascular Medicine | 2000 | 11 |
48 | A review of clinical trials in dietary interventions to decrease the incidence of coronary artery disease | Current Controlled Trials in Cardiovascular Medicine | 2001 | 11 |
49 | A trial design for evaluation of empiric programming of implantable cardioverter defibrillators to improve patient management | Current Controlled Trials in Cardiovascular Medicine | 2004 | 11 |
50 | Medical errors: how the US Government is addressing the problem | Current Controlled Trials in Cardiovascular Medicine | 2000 | 9 |